2025-07-16 - Analysis Report
Okay, here's the report, broken down as requested.

## Hims & Hers Health Inc (HIMS) Analysis - July 17, 2025

Hims & Hers Health Inc (HIMS) is a telehealth company providing access to prescription medications and personal care products online.

### 1. Performance vs. S&P 500 (VOO)

*   **HIMS Cumulative Return:** 180.06%
*   **VOO Cumulative Return:** 63.59%
*   **Absolute Divergence:** 116.47%
*   **Relative Divergence:** 54.5 (On a scale where the minimum divergence is 0 and the maximum is 100)

**Analysis of Alpha, Beta, CAGR and MDD:**

| Year       | CAGR    | MDD    | Alpha   | Beta | Cap(B) |
|------------|---------|--------|---------|------|--------|
| 2019-2021  | -46.0%  | 51.0%  | -84.0%  | -0.0 | 1.5    |
| 2020-2022  | -15.0%  | 72.1%  | -17.0%  | -0.0 | 1.4    |
| 2021-2023  | -51.0%  | 72.1%  | -69.0%  | -0.1 | 2.0    |
| 2022-2024  | 127.0% | 78.4%  | 101.0% | -0.1 | 5.4    |
| 2023-2025  | 175.0% | 78.4%  | 128.0% | -0.1 | 11.3   |

**Analysis:**

*   **Cumulative Return:** HIMS has significantly outperformed the S&P 500 (VOO) over the observed period. The absolute divergence is substantial. The relative divergence suggests that the current outperformance is positioned in the upper half of its historical range relative to VOO.
*   **Alpha and Beta Analysis:**
    *   **CAGR:** The Compound Annual Growth Rate (CAGR) varies significantly across the years. Notably, from 2023 to 2025, HIMS showed a high CAGR of 175.0%, indicating substantial growth in recent years.
    *   **MDD:** The Maximum Drawdown (MDD) is high across all periods, indicating significant volatility and potential risk.
    *   **Alpha:** The Alpha values are mixed but show strong positive performance in the most recent periods. For example, from 2023 to 2025, the Alpha is 128.0%, suggesting that HIMS significantly outperformed its expected return based on its risk-adjusted model.
    *   **Beta:** The Beta values are negative and close to zero, indicating a low correlation with the market and potentially defensive characteristics.
    *   **Cap:** The Market Capitalization has increased significantly, especially from 2022 to 2025, indicating growing investor confidence and market valuation.

### 2. Recent Stock Price Fluctuations

*   **Current Price:** $50.46
*   **Previous Close:** $52.03
*   **Change:** -3.02
*   **5-Day Moving Average:** 50.378
*   **20-Day Moving Average:** 50.4286
*   **60-Day Moving Average:** 49.2704

**Analysis:** The stock price has recently decreased, as evidenced by the negative change. The 5-day and 20-day moving averages are very close to the current price, suggesting the price is currently stable. The 60-day moving average is lower, indicating an overall upward trend in the recent past. The recent price drop of -3.02 suggests a notable downward movement.

### 3. Market Risk Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.341 (Low Risk)
*   **RSI:** 64.56
*   **PPO:** 0.3791
*   **Hybrid Signal:** cash_3%_Buy 80% of cash (445 shares - Caution - MRI:0.34) (Cash Ratio: 3% on 2025-07-15)
*   **20-Day Relative Divergence Change:** 0.2 (Positive)
*   **Expected Return:** -16.6%

**Analysis:**

*   **MRI:** The low MRI suggests a low-risk environment for the stock.
*   **RSI:** The RSI of 64.56 indicates that the stock is nearing overbought conditions but not yet in that territory.
*   **PPO:** The positive PPO indicates that the short-term moving average is above the long-term moving average, suggesting a potential uptrend.
*   **Hybrid Signal:** The hybrid signal suggests a "Buy" recommendation with caution, likely due to the recent price decrease.
*   **20-Day Relative Divergence Change:** The positive change in relative divergence suggests a recent upward trend in outperformance compared to the S&P 500.
*   **Expected Return:** The negative expected return suggests that, over the long term (2+ years), the stock is expected to underperform the S&P 500, especially concerning 적립 투자.

### 4. Recent News & Significant Events

*   **2025-07-12:** Major business developments, regulatory changes, or market events.
*   **2025-07-16:** Analysts discussing performance in the context of industry and global economics.
*   **2025-07-14:** Notable stock volatility due to news, earnings, or executive actions.
*   **2025-07-13:** Market experts highlighting risks and opportunities, advising monitoring of news.

**Analysis:** The recent news suggests that HIMS is experiencing significant activity, including volatility and analyst attention. Investors should closely monitor news and company announcements.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-05-05 | 0.22  | 0.59 B$    |
| 2024-11-04 | 0.35  | 0.40 B$    |
| 2024-08-05 | 0.06  | 0.32 B$    |
| 2024-05-06 | 0.05  | 0.28 B$    |
| 2025-05-05 | 0.05  | 0.28 B$    |

**Analysis:**

*   **EPS:** The EPS (Earnings Per Share) shows volatility but generally an upward trend, peaking at 0.35 in 2024-11-04. The more recent figure of 0.22 in 2025-05-05 indicates a slight decrease, but is still higher than in the past.
*   **Revenue:** Revenue has generally increased over the periods reported, with the latest reported revenue at $0.59B. This suggests strong sales growth.
*   **Trend:** The company appears to be on a growth trajectory, with both EPS and revenue increasing over time.

### 6. Financial Information

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-03-31   | $0.59B   | 73.50%        |
| 2024-12-31   | $0.48B   | 76.81%        |
| 2024-09-30   | $0.40B   | 79.16%        |
| 2024-06-30   | $0.32B   | 81.30%        |
| 2024-03-31   | $0.28B   | 82.36%        |

| Quarter      | Equity   | ROE      |
|--------------|----------|----------|
| 2025-03-31   | $0.55B   | 9.01%   |
| 2024-12-31   | $0.48B   | 5.46%    |
| 2024-09-30   | $0.44B   | 17.18%   |
| 2024-06-30   | $0.36B   | 3.67%    |
| 2024-03-31   | $0.34B   | 3.23%    |

**Analysis:**

*   **Revenue & Profit Margin:** Revenue is increasing, but the profit margin is decreasing.  While revenue growth is positive, the declining profit margin is a potential concern and needs further investigation.
*   **Equity & ROE:** Equity is increasing, suggesting the company is growing its asset base. ROE (Return on Equity) is volatile, with a peak in 2024-09-30.

### 7. Overall Analysis

Hims & Hers Health Inc (HIMS) has demonstrated strong historical outperformance compared to the S&P 500. Recent performance data indicates some short-term volatility. The MRI suggests a low-risk environment.

**Key Points:**

*   **Strengths:** Significant outperformance vs. S&P 500 (VOO), recent upward trend in revenue, increasing equity, a low MRI.
*   **Weaknesses:** High MDD, potentially concerning decline in profit margins, recent negative expected return (long-term underperformance vs. S&P 500). Recent price volatility and a downward trend.
*   **Considerations:** Investors should closely monitor news and company announcements due to recent volatility and analyst attention. The decreasing profit margin warrants further investigation. While historical performance is strong, the negative expected return for long-term investment is a concern.

**Recommendation:** The "Hybrid Signal" is cautiously positive, but due to the potential weaknesses, investors should be cautious, especially for long-term investments. Further investigation into the declining profit margin and the reasons behind the negative expected return is recommended before making any investment decisions.
